Westlake S, Cooper N: Cancer incidence and mortality: trends in the United Kingdom and constituent countries, 1993 to 2004. Health Stat Q. 2008, 33-46. 38
PubMed
Google Scholar
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 2008, 58 (2): 71-96. 10.3322/CA.2007.0010.
Article
PubMed
Google Scholar
Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colás E, Llauradó M, Alazzouzi H, Planagumá J, Lohmann MA, Garcia J, Castellvi S, Ramon y Cajal J, Gil-Moreno A, Xercavins J, Alameda F, Reventós J: Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol. 2008, 108 (3-5): 221-229. 10.1016/j.jsbmb.2007.09.020.
Article
CAS
PubMed
Google Scholar
Jabbour HN, Sales KJ, Smith OP, Battersby S, Boddy SC: Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol. 2006, 252 (1-2): 191-200. 10.1016/j.mce.2006.03.025.
Article
CAS
PubMed
Google Scholar
Tong BJ, Tan J, Tajeda L, Das SK, Chapman JA, DuBois RN, Dey SK: Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia. 2000, 2 (6): 483-490. 10.1038/sj.neo.7900119.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tsuji S, Kawano S, Sawaoka H, Takei Y, Kobayashi I, Nagano K, Fusamoto H, Kamada T: Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot Essent Fatty Acids. 1996, 55 (3): 179-183. 10.1016/S0952-3278(96)90095-2.
Article
CAS
PubMed
Google Scholar
Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995, 83 (3): 493-501. 10.1016/0092-8674(95)90127-2.
Article
CAS
PubMed
Google Scholar
Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998, 93 (5): 705-716. 10.1016/S0092-8674(00)81433-6.
Article
CAS
PubMed
Google Scholar
Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971, 285 (21): 1182-1186. 10.1056/NEJM197111182852108.
Article
CAS
PubMed
Google Scholar
Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003, 3 (6): 401-410. 10.1038/nrc1093.
Article
CAS
PubMed
Google Scholar
Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res. 1977, 14 (1): 53-65. 10.1016/0026-2862(77)90141-8.
Article
CAS
PubMed
Google Scholar
Sales KJ, Boddy SC, Williams AR, Anderson RA, Jabbour HN: F-prostanoid receptor regulation of fibroblast growth factor 2 signalling in endometrial adenocarcinoma cells. Endocrinology. 2007, 148 (8): 3635-3644. 10.1210/en.2006-1517.
Article
CAS
PubMed
Google Scholar
Sales KJ, List T, Boddy SC, Williams AR, Anderson RA, Naor Z, Jabbour HN: A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res. 2005, 65 (17): 7707-7716.
PubMed Central
CAS
PubMed
Google Scholar
Soufla G, Sifakis S, Spandidos DA: FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium. Cancer Lett. 2008, 259 (2): 146-155. 10.1016/j.canlet.2007.10.002.
Article
CAS
PubMed
Google Scholar
Danielsen T, Rofstad EK: VEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts. Int J Cancer. 1998, 76 (6): 836-841. 10.1002/(SICI)1097-0215(19980610)76:6<836::AID-IJC12>3.0.CO;2-0.
Article
CAS
PubMed
Google Scholar
Rofstad EK, Halsor EF: Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res. 2000, 60 (17): 4932-4938.
CAS
PubMed
Google Scholar
Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M: Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol. 2000, 130 (3): 641-649. 10.1038/sj.bjp.0703327.
Article
PubMed Central
CAS
PubMed
Google Scholar
Auguste P, Javerzat S, Bikfalvi A: Regulation of vascular development by fibroblast growth factors. Cell Tissue Res. 2003, 314 (1): 157-166. 10.1007/s00441-003-0750-0.
Article
CAS
PubMed
Google Scholar
Konerding MA, Fait E, Dimitropoulou C, Malkusch W, Ferri C, Giavazzi R, Coltrini D, Presta M: Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. Am J Pathol. 1998, 152 (6): 1607-1616.
PubMed Central
CAS
PubMed
Google Scholar
Wang Y, Becker D: Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med. 1997, 3 (8): 887-893. 10.1038/nm0897-887.
Article
CAS
PubMed
Google Scholar
Folkman J, Haudenschild C: Angiogenesis in vitro. Nature. 1980, 288 (5791): 551-556. 10.1038/288551a0.
Article
CAS
PubMed
Google Scholar
Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996, 86 (3): 353-364. 10.1016/S0092-8674(00)80108-7.
Article
CAS
PubMed
Google Scholar
Adams RH, Alitalo K: Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007, 8 (6): 464-478. 10.1038/nrm2183.
Article
CAS
PubMed
Google Scholar
Kanda S, Hodgkin MN, Woodfield RJ, Wakelam MJ, Thomas G, Claesson-Welsh L: Phosphatidylinositol 3'-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells. J Biol Chem. 1997, 272 (37): 23347-23353. 10.1074/jbc.272.37.23347.
Article
CAS
PubMed
Google Scholar
Sulpice E, Bryckaert M, Lacour J, Contreres JO, Tobelem G: Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway. Blood. 2002, 100 (9): 3087-3094. 10.1182/blood.V100.9.3087.
Article
CAS
PubMed
Google Scholar
Peng CY, Pan SL, Lee KH, Bastow KF, Teng CM: Molecular mechanism of the inhibitory effect of KS-5 on bFGF-induced angiogenesis in vitro and in vivo. Cancer Lett. 2008, 263 (1): 114-121. 10.1016/j.canlet.2007.12.028.
Article
CAS
PubMed
Google Scholar
Eliceiri BP, Klemke R, Stromblad S, Cheresh DA: Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol. 1998, 140 (5): 1255-1263. 10.1083/jcb.140.5.1255.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, Donner DB: Utilization of distinct signalling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem. 2000, 275 (7): 5096-5103. 10.1074/jbc.275.7.5096.
Article
CAS
PubMed
Google Scholar
Lewis TS, Shapiro PS, Ahn NG: Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998, 74: 49-139. full_text.
Article
CAS
PubMed
Google Scholar
Thomas SM, Brugge JS: Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997, 13: 513-609. 10.1146/annurev.cellbio.13.1.513.
Article
CAS
PubMed
Google Scholar
Kilarski WW, Jura N, Gerwins P: Inactivation of Src family kinases inhibits angiogenesis in vivo: implications for a mechanism involving organization of the actin cytoskeleton. Exp Cell Res. 2003, 291 (1): 70-82. 10.1016/S0014-4827(03)00374-4.
Article
CAS
PubMed
Google Scholar
Koh W, Sachidanandam K, Stratman AN, Sacharidou A, Mayo AM, Murphy EA, Cheresh DA, Davis GE: Formation of endothelial lumens requires a coordinated PKC{epsilon}-, Src-, Pak- and Raf-kinase-dependent signalling cascade downstream of Cdc42 activation. J Cell Sci. 2009, 122 (11): 1812-1822. 10.1242/jcs.045799.
Article
PubMed Central
CAS
PubMed
Google Scholar
Guertin DA, Sabatini DM: Defining the role of mTOR in cancer. Cancer Cell. 2007, 12 (1): 9-22. 10.1016/j.ccr.2007.05.008.
Article
CAS
PubMed
Google Scholar
Lee DF, Hung MC: All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle. 2007, 6 (24): 3011-3014. 10.4161/cc.6.24.5085.
Article
CAS
PubMed
Google Scholar
Drakos E, Rassidakis GZ, Medeiros LJ: Mammalian target of rapamycin (mTOR) pathway signalling in lymphomas. Expert Rev Mol Med. 2008, 10: e4-10.1017/S1462399408000586.
Article
PubMed
Google Scholar
Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q, Richmond A, Strieter R, Dey SK, DuBois RN: CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med. 2006, 203 (4): 941-951. 10.1084/jem.20052124.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jabbour HN, Sales KJ: Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab. 2004, 15 (8): 398-404.
Article
CAS
PubMed
Google Scholar
Qian RZ, Yue F, Zhang GP, Hou LK, Wang XH, Jin HM: Roles of cyclooxygenase-2 in microvascular endothelial cell proliferation induced by basic fibroblast growth factor. Chin Med J (Engl). 2008, 121 (24): 2599-2603.
CAS
Google Scholar
Finetti F, Solito R, Morbidelli L, Giachetti A, Ziche M, Donnini S: Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1. J Biol Chem. 2008, 283 (4): 2139-2146. 10.1074/jbc.M703090200.
Article
CAS
PubMed
Google Scholar
Rao R, Redha R, Macias-Perez I, Su Y, Hao C, Zent R, Breyer MD, Pozzi A: Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J Biol Chem. 2007, 282 (23): 16959-16968. 10.1074/jbc.M701214200.
Article
CAS
PubMed
Google Scholar
Tamura K, Sakurai T, Kogo H: Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vascul Pharmacol. 2006, 44 (6): 411-416. 10.1016/j.vph.2006.02.009.
Article
CAS
PubMed
Google Scholar
Taylor L, Foxall T, Auger K, Heinsohn C, Polgar P: Comparison of prostaglandin synthesis by endothelial cells from blood vessels originating in the rat, baboon, calf and human. Atherosclerosis. 1987, 65 (3): 227-236. 10.1016/0021-9150(87)90038-4.
Article
CAS
PubMed
Google Scholar
Sales KJ, Milne SA, Williams AR, Anderson RA, Jabbour HN: Expression, localization, and signalling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signalling pathways. J Clin Endocrinol Metab. 2004, 89 (2): 986-993. 10.1210/jc.2003-031434.
Article
CAS
PubMed
Google Scholar
Sales KJ, Battersby S, Williams AR, Anderson RA, Jabbour HN: Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signalling pathway. J Clin Endocrinol Metab. 2004, 89 (12): 6112-6118. 10.1210/jc.2004-0892.
Article
CAS
PubMed
Google Scholar
Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN: Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res. 2002, 62 (2): 424-432.
PubMed Central
CAS
PubMed
Google Scholar
Battersby S, Sales KJ, Williams AR, Anderson RA, Gardner S, Jabbour HN: Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway. Hum Reprod. 2007, 22 (1): 36-44. 10.1093/humrep/del328.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ledingham MA, Denison FC, Kelly RW, Young A, Norman JE: Nitric oxide donors stimulate prostaglandin F(2alpha) and inhibit thromboxane B(2) production in the human cervix during the first trimester of pregnancy. Mol Hum Reprod. 1999, 5 (10): 973-982. 10.1093/molehr/5.10.973.
Article
CAS
PubMed
Google Scholar
Denison FC, Calder AA, Kelly RW: The action of prostaglandin E2 on the human cervix: stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor. Am J Obstet Gynecol. 1999, 180 (3 Pt 1): 614-620. 10.1016/S0002-9378(99)70263-2.
Article
CAS
PubMed
Google Scholar